AIMC Topic: Drug Repositioning

Clear Filters Showing 91 to 100 of 296 articles

Drug Repositioning Based on Deep Sparse Autoencoder and Drug-Disease Similarity.

Interdisciplinary sciences, computational life sciences
Drug repositioning is critical to drug development. Previous drug repositioning methods mainly constructed drug-disease heterogeneous networks to extract drug-disease features. However, these methods faced difficulty when we are using structurally si...

SiSGC: A Drug Repositioning Prediction Model Based on Heterogeneous Simplifying Graph Convolution.

Journal of chemical information and modeling
Drug repositioning plays a key role in disease treatment. With the large-scale chemical data increasing, many computational methods are utilized for drug-disease association prediction. However, most of the existing models neglect the positive influe...

Identification of new potential candidates to inhibit EGF via machine learning algorithm.

European journal of pharmacology
One of the cost-effective alternative methods to find new inhibitors has been the repositioning approach of existing drugs. The advantage of computational drug repositioning method is saving time and cost to remove the pre-clinical step and accelerat...

A novel efficient drug repurposing framework through drug-disease association data integration using convolutional neural networks.

BMC bioinformatics
Drug repurposing is an exciting field of research toward recognizing a new FDA-approved drug target for the treatment of a specific disease. It has received extensive attention regarding the tedious, time-consuming, and highly expensive procedure wit...

Repositioning of Ureteropelvic Junction in Robot-assisted Laparoscopic Pyeloplasty.

Urology
OBJECTIVE: To describe the technique of ureteropelvic junction (UPJ) repositioning in robot-assisted dismembered pyeloplasty as a modified approach during which the UPJ is brought to a new location to facilitate the anastomosis.

Protocol to implement a computational pipeline for biomedical discovery based on a biomedical knowledge graph.

STAR protocols
Biomedical knowledge graphs (BKGs) provide a new paradigm for managing abundant biomedical knowledge efficiently. Today's artificial intelligence techniques enable mining BKGs to discover new knowledge. Here, we present a protocol for implementing a ...

Uncovering hidden therapeutic indications through drug repurposing with graph neural networks and heterogeneous data.

Artificial intelligence in medicine
Drug repurposing has gained the attention of many in the recent years. The practice of repurposing existing drugs for new therapeutic uses helps to simplify the drug discovery process, which in turn reduces the costs and risks that are associated wit...

EGeRepDR: An enhanced genetic-based representation learning for drug repurposing using multiple biomedical sources.

Journal of biomedical informatics
MOTIVATION: Drug repurposing (DR) is an imminent approach for identifying novel therapeutic indications for the available drugs and discovering novel drugs for previously untreatable diseases. Nowadays, DR has major attention in the pharmaceutical in...

Multi-Label Classification With Dual Tail-Node Augmentation for Drug Repositioning.

IEEE/ACM transactions on computational biology and bioinformatics
Due to the lengthy and costly process of new drug discovery, increasing attention has been paid to drug repositioning, i.e., identifying new drug-disease associations. Current machine learning methods for drug repositioning mainly leverage matrix fac...

Discovering the mechanism of action of drugs with a sparse explainable network.

EBioMedicine
BACKGROUND: Although Deep Neural Networks (DDNs) have been successful in predicting the efficacy of cancer drugs, the lack of explainability in their decision-making process is a significant challenge. Previous research proposed mimicking the Gene On...